Supporting the goals and ideals of "Deep Vein Thrombosis and Pulmonary Embolism Awareness Month".

Gregory F. Murphy

Republican · NC · Representative

Source: Congress.gov · FEC

• Paul Tonko (D-NY-20)Original· 2026-03-12

Referred to the House Committee on Energy and Commerce.

2026-03-12

Source: Congress.gov

This resolution supports a national awareness month dedicated to educating the public about deep vein thrombosis (blood clots in the legs) and pulmonary embolism (blood clots in the lungs), two serious and sometimes life-threatening conditions that affect hundreds of thousands of Americans each year. The measure encourages healthcare providers, patients, and the public to learn about the warning signs, risk factors, and prevention methods for these conditions. It aims to increase understanding of these often-overlooked health threats and promote early detection and treatment.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H. Res. 1112 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. RES. 1112 Supporting the goals and ideals of ``Deep Vein Thrombosis and Pulmonary Embolism Awareness Month''. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES March 12, 2026 Mr. Murphy (for himself and Mr. Tonko) submitted the following resolution; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ RESOLUTION Supporting the goals and ideals of ``Deep Vein Thrombosis and Pulmonary Embolism Awareness Month''. Whereas deep vein thrombosis (referred to in this preamble as ``DVT'') is a condition that occurs when a blood clot forms in the deep veins of the body, such as in the arm, abdomen, around the brain, and most commonly in the leg; Whereas a potentially life-threatening complication of DVT is a pulmonary embolism (referred to in this preamble as a ``PE''), where a blood clot breaks off, travels through the blood stream, and lodges in the lung; Whereas DVT and PEs are serious but often preventable medical conditions; Whereas DVT and PEs affect as many as 900,000 individuals in the United States each year; Whereas DVT and PEs kill an estimated 60,000 to 100,000 individuals in the United States each year, and 1 out of 4 individuals who have a PE die without warning; Whereas deaths caused by DVT and PEs are often preventable; Whereas DVT and PEs are among the leading causes of preventable hospital deaths in the United States; Whereas DVT and PEs are common complications faced by cancer patients, and survival rates are lower for individuals with cancer who also have blood clots; Whereas pregnancy increases the risk of DVT and PEs, and that risk remains elevated for up to 3 months after giving birth; Whereas immobility, surgery, older age, and a family history of clotting and thrombophilia increase the risk of DVT and PEs; Whereas DVT and PEs contribute to up to $10,000,000,000 in incremental medical costs each year in the United States; and Whereas the establishment of March as ``Deep Vein Thrombosis and Pulmonary Embolism Awareness Month'' would raise awareness about these life- threatening but preventable conditions: Now, therefore, be it Resolved, That the Senate-- (1) supports the goals and ideals of ``Deep Vein Thrombosis and Pulmonary Embolism Awareness Month''; and (2) recognizes the importance of raising awareness of deep vein thrombosis and pulmonary embolisms. <all>

• HR8163Provider Reimbursement Stability Act of 2026
  Referred to Committee · 2026-05-21
• HR6583VA Research Reform Act of 2025
  Referred to Committee · 2026-05-20
• HR8553To direct the Secretary of Veterans Affairs to establish a precision oncology program for cancer of the prostate, and for other purposes.
  Referred to Committee · 2026-04-28
• HR8344Senior Citizens’ Freedom to Work Act of 2026
  Referred to Committee · 2026-04-16